drugset / Trial / NCT00999141

Efficacy and Safety of FS VH S/D 4 S-apr for Flap Adherence in Rhytidectomy

NCT00999141 ↗

Phase 3 Completed 75 enrolled Baxter Healthcare Corporation
RandomizedSingle-groupSingle-blindTreatment

Summary

The purpose of the study is to compare the safety and efficacy of FS VH S/D 4 s-apr versus standard of care in adhering tissue and improving wound healing in subjects undergoing facelift.

Timeline

Start
2009-09
Primary completion
2009-12
Completion
2010-02

Outcome

Met primary endpoint

registry analysis (superiority or other test); Standard of Care (SoC) vs FS VH S/D 4 S-apr; p <0.0001; two-sided paired t-test NCT00999141 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject FS VH S/D 4 s-apr Protein / enzyme biologic — Topical

Indications

No indication recorded.